Literature DB >> 23490338

[Drug-induced fever: a diagnosis to remember].

D Vodovar1, C Le Beller2, A Lillo-Le-Louet2, T Hanslik3, B Megarbane4.   

Abstract

Drug fever (DF) is a febrile reaction induced by a drug without additional clinical features like skin eruption. This adverse drug reaction is probably common but under diagnosed. While its outcome is generally favourable, DF generates unnecessary diagnostic procedures as well as hospitalisations or hospitalisation prolongations. Clinical presentation and biological findings are not specific. Fever is generally well tolerated but may be accompanied by general symptoms mimicking sepsis. Moderate biological disorders could be expected, including elevation or decrease in white blood cell count, eosinophilia, liver cytolysis, and increased C-reactive protein. An infection should be systematically ruled out. Clinical or biological signs of severity should question DF diagnosis. When DF is suspected, the involved drug(s) should be stopped after a reliable assessment of imputability. Antibiotics represent the most often implicated drugs. Fever disappearance after discontinuing the suspected drug is the cornerstone of DF diagnosis. Before stopping the administration of the suspected drug(s), a risk/benefit ratio assessment is necessary. Consistently, it may be complicated to stop an antimicrobial drug when treating an infection or an immunosuppressive drug if required.
Copyright © 2013. Published by Elsevier SAS.

Entities:  

Keywords:  Adverse drug reaction; Antibiotic; Antibiotique; Beta-lactamin; Béta-lactamine; Drug fever; Effet indésirable médicamenteux; Fever of unknown origin; Fièvre au long cours; Fièvre médicamenteuse

Mesh:

Year:  2013        PMID: 23490338     DOI: 10.1016/j.revmed.2013.02.023

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  1 in total

1.  Antibiotic-induced fever in orthopaedic patients-a diagnostic challenge.

Authors:  Kirsten Labbus; Jana Karina Junkmann; Carsten Perka; Andrej Trampuz; Nora Renz
Journal:  Int Orthop       Date:  2018-03-29       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.